13D Filing: Farallon Capital and Nexvet Biopharma PLC (NVET)

Page 34 of 68

Page 34 of 68 – SEC Filing

executed by each of Dreyfuss, Paidipaty and Seybold authorizing Landry to sign and file this Schedule 13D on his behalf, which were filed as exhibits to the Schedule 13G filed with the SEC on January 11, 2017 by such Reporting Persons with respect to the Common Stock of Sky Solar Holdings, Ltd., are hereby incorporated by reference.
ANNEX 1
Set forth below with respect to the Management Company, the Farallon General Partner, the NSSP General Partner, the FCAAI General Partner and the FSSP VI General Partner is the following information:  (a) name; (b) address; (c) principal business; (d) state of organization; and (e) controlling persons.  Set forth below with respect to each managing member of the Management Company and the Farallon General Partner is the following information:  (a) name; (b) business address; (c) principal occupation; and (d) citizenship.
1.
The Management Company
(a)
Farallon Capital Management, L.L.C.
(b)
One Maritime Plaza, Suite 2100
San Francisco, California  94111
(c)
Serves as investment adviser to various managed accounts
(d)
Delaware limited liability company
(e)
Managing Members:  Andrew J. M. Spokes, Senior Managing Member; and Philip D. Dreyfuss, Michael B. Fisch, Richard B. Fried, David T. Kim, Monica R. Landry, Michael G. Linn, Ravi K. Paidipaty, Rajiv A. Patel, Thomas G. Roberts, Jr., William Seybold, Gregory S. Swart, John R. Warren and Mark C. Wehrly, Managing Members.
2.
The Farallon General Partner
(a)
Farallon Partners, L.L.C.
(b)
c/o Farallon Capital Management, L.L.C.
One Maritime Plaza, Suite 2100
San Francisco, California  94111
(c)
Serves as general partner of investment partnerships
(d)
Delaware limited liability company
(e)
Managing Members:  Andrew J. M. Spokes, Senior Managing Member; and Philip D. Dreyfuss, Michael B. Fisch, Richard B. Fried, David T. Kim, Monica R. Landry, Michael G. Linn, Ravi K. Paidipaty, Rajiv A. Patel, Thomas G. Roberts, Jr., William Seybold, Gregory S. Swart, John R. Warren and Mark C. Wehrly, Managing Members.
4. The NSSP General Partner
(a) NGP, L.L.C.
(b)
c/o Farallon Capital Management, L.L.C.
One Maritime Plaza, Suite 2100
San Francisco, California  94111
(c)
Serves as general partner of investment partnerships
(d)
Delaware limited liability company
(e)
Manager: Farallon Capital Management, L.L.C.
5. The FCAAI General Partner
(a)
Farallon AA GP, L.L.C.
(b)
c/o Farallon Capital Management, L.L.C.

Follow Nexvet Biopharma Plc (NASDAQ:NVET)

Page 34 of 68